Cargando…
依布替尼通过新型途径克服弥漫大B细胞淋巴瘤细胞耐药机制的研究
OBJECTIVE: To explore the mechanism of ibrutinib on drug resistance diffuse large B-cell lymphoma (DLBCL) cells. METHODS: DLBCL cell line was cultured with mesenchymal stem cells (MSC), and DLBCL cells which migrated and adhered to MSC under microscope was counted. The secretion of CXCL12 by MSC wer...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342183/ https://www.ncbi.nlm.nih.gov/pubmed/29365396 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.12.006 |